MSCIMSCI
この企業紹介の日本語訳は準備中です。以下は英語の原文です。
MSCIについて
MSCI Inc. is a provider of investment decision-support tools, best known for the equity indexes that carry its name and serve as benchmarks for global institutional portfolios. Its business is organized into several lines: an Index franchise that licenses benchmarks to asset managers, ETF sponsors, and derivatives exchanges; an Analytics unit selling risk and performance systems used by asset owners and managers; an ESG and Climate operation providing ratings, screens, and climate-transition data; and a Private Assets segment covering real estate and private capital analytics, expanded through acquisition. The Index segment typically generates the bulk of operating profit, reflecting its high margins, recurring licensing model, and asset-linked fee streams tied to ETFs and passive mandates that reference MSCI benchmarks.
Investors track the sensitivity of asset-based fees to global equity market levels and to flows into passive vehicles that license MSCI indexes, which introduces cyclicality distinct from the subscription lines. Concentration among the largest ETF sponsors and asset managers is a recurring consideration, as is competitive pressure from rival index providers and in-house benchmarks. Regulatory scrutiny of index administration and of ESG rating methodologies in the European Union, the United Kingdom, and the United States is monitored closely, as is MSCI's stance on including or reweighting individual country markets, notably China. Capital allocation has emphasized dividends, opportunistic buybacks, and bolt-on acquisitions, with leverage managed against a stated target range.
The company traces its lineage to index products developed within Capital International beginning in the late 1960s and later branded jointly with Morgan Stanley as MSCI. Morgan Stanley acquired the business in 2004 and floated it as a public company under the MSCI ticker in November 2007, completing a full separation in 2009. A transformative combination with risk-analytics firm RiskMetrics closed in 2010, adding the Analytics platform and the ratings franchise later spun into the ESG unit. Subsequent acquisitions built out real estate analytics through IPD and private-capital coverage through Burgiss and Real Capital Analytics, shaping the current four-segment structure headquartered in New York.
Revenue is dominated by recurring subscriptions to institutional customers — asset managers, asset owners, hedge funds, banks, insurers, wealth platforms, and corporates — sold under multi-year contracts with high retention rates that management tracks as a core operating metric. Index revenue additionally includes asset-based fees paid by ETF issuers and exchanges licensing MSCI benchmarks for funds and listed derivatives, scaling with assets under management and traded volumes. Competitive position rests on the entrenched status of MSCI benchmarks in institutional mandates, the switching costs of embedded analytics workflows, and proprietary datasets. Principal rivals include S&P Dow Jones Indices, FTSE Russell, Bloomberg, and specialist ESG and private-markets vendors. Revenue is geographically diversified across the Americas, EMEA, and Asia-Pacific.
企業プロフィールはLineVest編集部によるものです。ジャーナリズムであり、投資助言ではありません。 MSCIのSECベース詳細レポートを依頼 →
MSCI関連記事
記事3件
South Korea Stays in MSCI Emerging Markets for Third Straight Year as Won Convertibility Gap Delays USD 24 Billion Inflow to 2028
MSCI keeps South Korea classified as an emerging market in its 2026 review, citing limited Korean won convertibility. A developed-market upgrade—worth an estimated USD 24 billion in passive fund inflows—is now deferred to 2028 at earliest.

Korea Gains a Point on MSCI Scorecard, but Wednesday's Reclassification Review Is the Real Test
MSCI cut Korea's minus-rated accessibility categories to five from six, upgrading investment-instrument availability. The annual classification review on June 23 will determine whether Korea re-enters the developed-market watchlist for the first time since 2014.

MSCI Cuts Three Korean Stocks in May Review, Shrinking Korea Index to 77
MSCI deleted Hanjin KAL, HD Hyundai Marine Solution and SK Biopharmaceuticals from the MSCI Korea Index in its May 2026 review, with no Korean additions.
見出しの先を読む
何が起きたかは読みました。次は、それが何を意味するかを。
米国市場を毎朝 — 無料で
LineVest Dailyが寄付き前に届きます:米国市場の主要ストーリー、決算、開示、外国人フロー — わかりやすい英語で。無料、カード登録不要。
一次資料のSEC開示に基づく独立ジャーナリズム — 投資助言ではありません。証券会社との提携はありません。